Literature DB >> 24742450

Current management strategies for systemic sclerosis.

Svetlana I Nihtyanova1, Voon H Ong, Christopher P Denton.   

Abstract

Systemic sclerosis remains a challenging disease despite progress that has taken place in the management of organ-based complications. Overall management strategies need to take into account the features of the disease that are common to almost all patients such as skin involvement, gastro-oesophageal manifestations and secondary Raynaud's, as well as identify less frequent but critical manifestations that impact on survival including heart, lung, renal and more severe GI involvement. Treatments can be considered to be disease-modifying or symptomatic. In addition, it is important to address more generic problems such as the emotional, psychological and economic impact of a chronic autoimmune rheumatic disease. This article reviews general approaches to disease assessment and management and relates this to subset and stage of the condition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24742450

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

1.  Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis.

Authors:  Yena Kim; Yoojun Nam; Yeri Alice Rim; Ji Hyeon Ju
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

Review 2.  Calcineurin inhibitors in systemic sclerosis - a systematic literature review.

Authors:  Nina N Hofmann; Robert A Ambühl; Suzana Jordan; Oliver Distler
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-19       Impact factor: 3.625

3.  Immunosuppression use in early systemic sclerosis may be increasing over time.

Authors:  Ryan Park; Tatiana Nevskaya; Murray Baron; Janet E Pope
Journal:  J Scleroderma Relat Disord       Date:  2021-03-29

4.  Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis.

Authors:  Rositsa Karalilova; Maria Kazakova; Tanya Sapundzhieva; Valentin Dichev; Zguro Batalov; Victoria Sarafian; Anastas Batalov
Journal:  Rheumatol Int       Date:  2019-08-02       Impact factor: 2.631

5.  A prediction model for progressive disease in systemic sclerosis.

Authors:  Jessica Meijs; Anne A Schouffoer; Nina Ajmone Marsan; Theo Stijnen; Hein Putter; Maarten K Ninaber; Tom W J Huizinga; Jeska K de Vries-Bouwstra
Journal:  RMD Open       Date:  2015-12-01

6.  Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis.

Authors:  Grzegorz Helbig; Małgorzata Widuchowska; Anna Koclęga; Anna Kopińska; Magdalena Kopeć-Mędrek; Władysław B Gaweł; Adrianna Spałek; Jakub Żak; Iwona Grygoruk-Wiśniowska; Robert Liwoch; Eugeniusz Kucharz; Mirosław Markiewicz
Journal:  Clin Rheumatol       Date:  2017-12-18       Impact factor: 2.980

7.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Isabel M McFarlane; Manjeet S Bhamra; Alexandra Kreps; Sadat Iqbal; Firas Al-Ani; Carla Saladini-Aponte; Christon Grant; Soberjot Singh; Khalid Awwal; Kristaq Koci; Yair Saperstein; Fray M Arroyo-Mercado; Derek B Laskar; Purna Atluri
Journal:  Rheumatology (Sunnyvale)       Date:  2018-03-30

Review 8.  Telocytes in regenerative medicine.

Authors:  Yihua Bei; Fei Wang; Changqing Yang; Junjie Xiao
Journal:  J Cell Mol Med       Date:  2015-06-08       Impact factor: 5.310

Review 9.  Sclerodermic Cardiomyopathy-A State-of-the-Art Review.

Authors:  Adrian Giucă; Tea Gegenava; Carmen Marina Mihai; Ciprian Jurcuţ; Adrian Săftoiu; Diana Monica Gȋrniţă; Bogdan Alexandru Popescu; Nina Ajmone Marsan; Ruxandra Jurcuț
Journal:  Diagnostics (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.